Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.87
+0.01 (0.07%)
Mar 9, 2026, 2:52 PM EDT - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $2.29 billion as of March 9, 2026. Its market cap has increased by 86.01% in one year.
Market Cap
2.29B
Enterprise Value
2.20B
1-Year Change
86.01%
Ranking
Category
Stock Price
$14.87
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.29B, a decrease of -52.04%. That is a compound annual growth rate of -10.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Tango Therapeutics | 2.42B |
| Immunome | 2.38B |
| Disc Medicine | 2.33B |
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |